3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
11
Carcinoma, Renal Cell
11
Carcinoma, Non-Small-Cell Lung
11
Neoplasm Metastasis
6
Pancreatic Neoplasms
4
Lung Neoplasms
4
Carcinoma, Transitional Cell
4
Neoplasms
3
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Hepatocellular
3
Carcinoma
3
Brain Neoplasms
3
Urogenital Neoplasms
2
Urinary Bladder Neoplasms
2
Urethral Neoplasms
2
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Penile Neoplasms
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Glioblastoma
2
Colorectal Neoplasms
2
Carcinoma, Basal Cell
2
Vulvar Neoplasms
1
Ureteral Neoplasms
1
Urachal adenocarcinoma
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Somatostatinoma
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
larotrectinib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Ipilimumab
×
30 days
×
Clear all
No trials found.